Results 151 to 160 of about 2,141 (173)
Journal of Cardiovascular Pharmacology, 2021 : Atherosclerosis has been effectively avoided with many therapies that lower low-density lipoprotein cholesterol. However, significant cardiovascular burden remains.
Donald M. Black +3 more
semanticscholar +5 more sources
Cloning, Chromosomal Mapping, and Regulatory Properties of the Human Type 9 Adenylyl Cyclase (ADCY9)
Genomics, 1998 The type 9 adenylyl cyclase (AC9) is a widely distributed adenylyl cyclase that was originally cloned from a mouse cDNA library. Here we report the cloning, chromosomal mapping, and regulatory properties of human AC9 (HGMW-approved symbol ADCY9 ...
Beth M. Hacker +7 more
semanticscholar +5 more sources
European Heart Journal, 2019 The clinical benefits of the cholesterol ester transfer protein (CETP) inhibitor dalcetrapib are dependent on the ADCY9 gene, which encodes adenylate cyclase (AC) type 9 (AC9).
Yohann Rautureau +11 more
semanticscholar +4 more sources
American Journal of Medical Genetics, 2001 Chromosome 16p13 has been shown to display modest linkage signals for mood disorders in a number of studies. An interesting candidate gene in this region is the adenylate cyclase (AC) type 9 gene (ADCY9).
Tomoko Toyota +7 more
semanticscholar +5 more sources
Arteriosclerosis, Thrombosis, and Vascular Biology, 2018 Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the cholesteryl ester transfer protein (CETP) inhibitor dalcetrapib on cardiovascular events, atherosclerosis imaging and body weight variation.
Yohann Rautureau +28 more
semanticscholar +4 more sources